In Focus

13 Apr 21
The government has allocated 15% of its 2021 budget to healthcare.
6 Apr 21
The basis for hospital subsidies will be changed to per capita household income.
30 Mar 21
Human rights issues are seen to have discouraged investment in the region.
23 Mar 21
Deals in the biopharma sector tripled during the year.
16 Mar 21
Most local pharma firms hold the research on new drugs as their predominant strategy.
9 Mar 21
The government is integrating public and private hospitals as the healthcare system is at its breaking point.
2 Mar 21
Companies have also made investments in R&D as they shift away from generic drugs.
23 Feb 21
The government has recently encouraged the expansion of telemedicine.
16 Feb 21
However, the overall spending is just about 1% of GDP.
9 Feb 21
The transition to personalised healthcare is gaining momentum across most of Asia Pacific.
2 Feb 21
Vietnamese pharmas are looking to cooperate with foreign companies and investors.
26 Jan 21
Negotiating on price may have become obligatory for drugs to be included for reimbursement.
19 Jan 21
Risk communication emerged as the weakest link during the pandemic.
15 Dec 20
The market may soon serve more people than what some large hospitals currently can.
8 Dec 20
Authorities have pledged to advance the development of online diagnosis and treatment.
1 Dec 20
Amidst an ageing population, the country is building a factory for producing cancer drugs.
24 Nov 20
Amidst ageing population, reliance on income tax and insurance contribution is no longer enough.
17 Nov 20
A fall in elective surgeries in 2020 slowed the upward trends in costs.
10 Nov 20
The industry's footfall took a hit as non-emergency visits were discouraged.
4 Nov 20
Over two in three felt they might not be able to afford healthcare if they become severely disabled.
1 Nov 20
The country is unable to raise healthcare expenditure by more than 3.8% of GDP, compared to the APAC average of 6.64%.
28 Oct 20
The decision from the WTO is expected to come by end-2020.
21 Oct 20
Three of China's coronavirus vaccines are under trials in Asia and South America.
4 Sep 20
The system is expected to deliver early detection of cases, even when the probablity of infection is low.
13 Aug 20
The government has quickly made digital health platforms available to address the pandemic.
13 Aug 20
COVID-19 has forced the government to speed up the regulatort infrastructure around telemedicine initiatives.
30 Jul 20
The method will speed up the testing procedure by up to four times.
17 Jul 20
Funding for testing and treatment, among others, was cited as the reason behind the inefficiencies across Asia-Pacific.
1 Jul 20
The data collected through the program could be used to identify patterns for facilitating early detection of the disease.
3 Jun 20
Even markets with better capacity faced issues such as manpower shortage.
21 May 20
The country saw overwhelmed hospitals and disrupted routine services amidst the pandemic.
6 May 20
It has been receiving government support as a way to control the spread of the pandemic.
22 Apr 20
Priorly, less than a quarter of the population had used telemedicine.
8 Apr 20
Half of the clusters that outperformed the ecosystem were relevant to addressing COVID-19.
25 Mar 20
The government is expected to account for the majority of the spending.
11 Mar 20
The total deal size in Southeast Asia surged to $2.4b.
24 Feb 20
Overuse of care by medical practitioners is one of the factors driving up costs.
11 Feb 20
A bulk of drug intermediates are sourced from China.
29 Jan 20
Healthtech investments in H2 slowed significantly.
15 Jan 20
The country’s government has allocated $3.2b to the health sector.